Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).

Date Range:

	CRISPR Therapeutics	QIAGEN	Bio-Techne	Neurocrine Biosciences	Repligen
Symbol	NASDAQ:CRSP	NYSE:QGEN	NASDAQ:TECH	NASDAQ:NBIX	NASDAQ:RGEN
Price Information
Current Price	$125.69	$50.00	$361.69	$109.51	$212.39
52 Week Range	Buy	Buy	Buy	Buy	Buy
MarketRank™
Overall Score	1.5	1.7	1.8	2.1	1.5
Analysis Score	3.3	3.3	1.3	3.3	1.5
Community Score	2.7	2.3	2.3	3.6	2.6
Dividend Score	0.0	0.0	1.7	0.0	0.0
Ownership Score	1.7	0.8	1.7	1.7	1.7
Earnings & Valuation Score	0.0	1.9	1.9	1.9	1.9
Analyst Ratings
Consensus Recommendation	Buy	Buy	Buy	Buy	Buy
Consensus Price Target	$147.67	$56.37	$352.30	$129.22	$204.75
% Upside from Price Target	17.48% upside	12.74% upside	-2.60% downside	18.00% upside	-3.60% downside
Trade Information
Market Cap	$9.48 billion	$11.39 billion	$14.03 billion	$10.29 billion	$11.18 billion
Beta	2.37	0.41	1.13	1.01	0.94
Average Volume	2,488,645	972,289	194,645	910,338	380,833
Sales & Book Value
Annual Revenue	$289.59 million	$1.53 billion	$738.69 million	$788.10 million	$270.24 million
Price / Sales	32.74	7.46	19.00	13.05	41.35
Cashflow	$0.82 per share	$2.49 per share	$6.73 per share	$0.69 per share	$1.44 per share
Price / Cash	154.11	20.07	53.77	158.60	147.51
Book Value	$17.02 per share	$11.14 per share	$36.13 per share	$6.92 per share	$20.36 per share
Price / Book	7.38	4.49	10.01	15.83	10.43
Profitability
Net Income	$66.86 million	$-41,460,000.00	$229.30 million	$37.01 million	$21.41 million
EPS	$1.17	$1.43	$3.86	$0.39	$1.07
Trailing P/E Ratio	N/A	61.73	57.87	117.75	259.01
Forward P/E Ratio	N/A	20.41	61.83	30.25	127.95
P/E Growth	N/A	1.29	7.23	N/A	4.18
Net Margins	-273.10%	11.18%	32.69%	8.96%	13.40%
Return on Equity (ROE)	-20.72%	17.51%	12.20%	18.18%	6.58%
Return on Assets (ROA)	-18.35%	8.44%	8.09%	9.50%	5.00%
Dividend
Annual Payout	N/A	N/A	$1.28	N/A	N/A
Dividend Yield	N/A	N/A	0.35%	N/A	N/A
Three-Year Dividend Growth	N/A	N/A	N/A	N/A	N/A
Payout Ratio	N/A	N/A	33.16%	N/A	N/A
Years of Consecutive Dividend Growth	N/A	N/A	1 Years	N/A	N/A
Debt
Debt-to-Equity Ratio	N/A	0.52%	0.22%	N/A	0.21%
Current Ratio	16.53%	1.46%	5.14%	1.89%	13.67%
Quick Ratio	16.53%	1.22%	4.13%	1.86%	12.13%
Ownership Information
Institutional Ownership Percentage	66.43%	43.64%	93.75%	95.25%	84.33%
Insider Ownership Percentage	17.10%	9.00%	3.80%	4.30%	1.70%
Miscellaneous
Employees	304	5,300	2,300	845	761
Shares Outstanding	75.43 million	227.75 million	38.80 million	93.94 million	52.62 million
Next Earnings Date	4/27/2021 (Estimated)	5/5/2021 (Estimated)	4/29/2021 (Estimated)	5/5/2021 (Estimated)	5/5/2021 (Estimated)
Optionable	Optionable	Optionable	Optionable	Optionable	Optionable

Comparison Ideas:

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Your Ultimate Investing Toolkit

Just $1.00 for your first month.

Compare Stocks

30 Days of MarketBeat All Access for $1.00

Premium Research Tools

Market Data and Calendars

Investing Education and Resources